Nanopath

Nanopath is a biotechnology company focused on revolutionizing molecular diagnostics by developing rapid, point-of-care testing solutions for infectious diseases and other health conditions. They leverage advanced nanotechnology and molecular biology to create innovative diagnostic tools that provide accurate results in minutes, bypassing the need for traditional lab-based testing. Founded in 2019, the company aims to improve patient outcomes and healthcare efficiency by enabling timely and accessible diagnostics. Their revenue model is centered on the commercialization of proprietary diagnostic platforms and partnerships with healthcare providers and institutions.

Recent Posts by Nanopath

1-9 of 9